ADD ANI AS A TRUSTED SOURCE
googleads
Menu
US

Argentinian study proves high efficacy of Sputnik V in protecting people over 60: RDIF

Buenos Aires [Argentina], November 1 (ANI/Sputnik): A study conducted by the health ministry of the city of Buenos Aires, Argentina, showed high efficacy of the Russian-made COVID-19 vaccine Sputnik V in protecting people aged 60 and older, the Russian Direct Investment Fund (RDIF) said on Monday.

ANI Nov 01, 2021 13:45 IST googleads

Representative image

Buenos Aires [Argentina], November 1 (ANI/Sputnik): A study conducted by the health ministry of the city of Buenos Aires, Argentina, showed high efficacy of the Russian-made COVID-19 vaccine Sputnik V in protecting people aged 60 and older, the Russian Direct Investment Fund (RDIF) said on Monday.
"Results of the study are showing that infection rates decreased for over 88 per cent among those who received the full vaccination against COVID (2 doses). The full vaccination was associated with a 96.6 per cent reduction in mortality," the statement by the RDIF read.
As many as 660,000 elderly residents of Buenos Aires over 60 years of age, vaccinated with Sputnik V, AstraZeneca or Sinopharm, took part in the research, conducted in summer 2021.
The first dose of Sputnik V has also been proved to have 78.6-83.7 per cent efficacy in people aged 60-79 years, according to another study by the city's health ministry.
Most people in Buenos Aires have been vaccinated with the Russian vaccine, which contributed to a 15-fold decline in new COVID-19 cases within the past five months, according to the RDIF. (ANI/Sputnik)

Get the App

What to Read Next

Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Asia

"Global South emanates from shared history": EAM Jaishankar

EAM S Jaishankar stated that the era of "big deals" between dominant powers is over, as multipolarity is now an irreversible reality. He argued that the Global South is defined by shared historical experiences, while noting a growing "differentiation" within the previously unified Global West.

Read More
US

KV Subramanian wins prestigious Chicago Alumni Award

KV Subramanian wins prestigious Chicago Alumni Award

The University of Chicago has honoured Professor Krishnamurthy V. Subramanian with the Alumni Award for Professional Achievement. He is the first Indian economist to receive the 85-year-old distinction, recognised for his "landmark" policy work and leadership in India during the COVID-19 crisis and global economic uncertainty.

Read More
Asia

"AI outcome will not be accidental": CEA Anantha Nageswaran

Chief Economic Advisor V Anantha Nageswaran warns that AI's impact will depend on deliberate policy choices and must align with mass employability. At the India AI Impact Summit 2026, he called for urgent structural reforms, large-scale skilling, and stronger foundational education to address the skill gap and secure inclusive growth and stability.

Read More
Europe

"US trying to ban India from buying Russian energy": Lavrov

Russian Foreign Minister Sergey Lavrov took a dig at the United States in an interview with TV BRICS and said that there are efforts to ban India and other partners from purchasing Russian oil, Sputnik reported on Monday.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.